Research Article
Endovascular Management of Pseudo-Aneurysm of Hepatic Artery Arising from Superior Mesenteric Artery
Rajeev Bhardwaj,
Rajesh Nandal,
Ranjana Gupta,
Tania Pruthi,
Saurav Mittal
Issue:
Volume 9, Issue 5, September 2023
Pages:
75-78
Received:
7 September 2023
Accepted:
12 October 2023
Published:
28 October 2023
Abstract: Background: Visceral artery aneurysms occur in 0.01–0.2% of the population. Splenic artery is the most common affected followed by hepatic artery. However, pseudoaneurysm is more common in the hepatic artery. The symptoms are vague and most of the times, it is incidentally diagnosed on ultrasound or CT scan of abdomen. Ruptured pseudoaneurysm has high mortality. Hence, timely intervention is of paramount significance. Case information: We present a 48-year-old male who presented with pain epigastrium and jaundice and had been diagnosed with chronic pancreatitis. CT abdomen showed well defined round partially thrombosed right hepatic artery pseudo-aneurysm in relation to head of pancreas. The aberrant right hepatic artery was arising from super mesenteric artery. This hepatic artery pseudoaneurysm was managed successfully by implant of covered stent. Discussion: The treatment of visceral artery aneurysms involves either early surgery or endovascular treatment. Open surgical repair has very high mortality and morbidity. Open surgical repair is preferred in patients who are hemodynamically unstable and require emergency surgery. Conclusion: Hepatic artery pseudoaneurysm can be successfully managed by endovascular interventional techniques. Excluding pseudoaneurysm from parent artery by covered stent is a feasible option with high success rate and patency of feeding artery.
Abstract: Background: Visceral artery aneurysms occur in 0.01–0.2% of the population. Splenic artery is the most common affected followed by hepatic artery. However, pseudoaneurysm is more common in the hepatic artery. The symptoms are vague and most of the times, it is incidentally diagnosed on ultrasound or CT scan of abdomen. Ruptured pseudoaneurysm has h...
Show More
Research Article
Analysis of a Case of Colon Cancer Complicated with Diffuse Large B-Cell Lymphoma of the Spleen
Guoqing Huang,
Chulin Liang,
Mingzhi Sang,
Xuyou Liu
Issue:
Volume 9, Issue 5, September 2023
Pages:
79-84
Received:
26 September 2023
Accepted:
20 October 2023
Published:
31 October 2023
Abstract: Background: Primary splenic lymphoma (PSL) is a rare type of tumor that occurs in the spleen, generally without the involvement of intrasplenic organs and lymph nodes, and its incidence is less than 1% of lymphomas, most of which are non-Hodgkin's lymphomas (NHL). Diffuse large B-cell lymphoma (DL- BCL) often has atypical clinical manifestations, which makes clinical diagnosis difficult and is prone to misdiagnosis or omission, posing a significant challenge to clinical diagnosis and treatment. Colorectal cancer is the third most frequent cancer and the fourth most common cause of death in the world and is diagnosed on the basis of clinical manifestations, X-ray barium enema, or fibreoptic colonoscopy. The key to colorectal cancer treatment lies in early detection, timely diagnosis, and surgical eradication. Although lymphoma and colorectal cancer are some of the most frequent malignant tumours in adults, and there are guidelines for the diagnosis and treatment of both diseases, their co-occurrence is extremely uncommon, and there are fewer reports in the literature on the diagnosis and treatment of co-existing cases, and there is still no definitive and effective method for diagnosis, differential diagnosis and treatment. A case of splenic diffuse large B-cell lymphoma complicated with colon cancer was admitted to our hospital, and we now report its clinical data, conduct a literature review and analysis in order better to carry out clinical diagnosis, differential diagnosis and treatment, and summarize the diagnosis and comprehensive treatment experience of this disease. This case report provides ideas for the diagnosis and treatment of the disease.
Abstract: Background: Primary splenic lymphoma (PSL) is a rare type of tumor that occurs in the spleen, generally without the involvement of intrasplenic organs and lymph nodes, and its incidence is less than 1% of lymphomas, most of which are non-Hodgkin's lymphomas (NHL). Diffuse large B-cell lymphoma (DL- BCL) often has atypical clinical manifestations, w...
Show More
Research Article
Time-to-Recovery from Type 2 Diabetic Patients and Associated Aspects at Debre Berhan Specialized Hospital
Buzuneh Tasfa Marine,
Dagne Tesfaye Mengistie,
Kitesa Biresa Duftu
Issue:
Volume 9, Issue 5, September 2023
Pages:
85-97
Received:
30 September 2023
Accepted:
20 October 2023
Published:
31 October 2023
Abstract: Background: Diabetes mellitus, more often known as diabetes, is a dangerous, long-term (or "chronic") disorder that manifests as elevated blood glucose levels when the body is unable to create, sufficient amounts of, or utilize the insulin that is produced. Due to the fact that a single patient may recover from more than one type 2 diabetes throughout time, recovery is usually recurring. Worldwide, type 2 diabetes was expected to affect 422 million adults in 2014, up from 108 million in 1980. By 2045, the International Diabetes Federation (IDF) projects that there will be a 143% rise in the population of diabetics in Africa. Ethiopia had 80,000 cases of diabetes in 2000, and the WHO projects that number will increase to 1.8 million cases by 2030. The aim of this research was to evaluate the type 2 diabetes recurrence (time to recovery) along with associated variables at Debre Berhan Specialized Hospital in Ethiopia. Methodology: An institutional-based retrospective study design was carried out on data obtained from Debre Berhan Specialized Hospital, in Jimma zones with type 2 diabetic patients who started treatment and were on follow-up in this Hospital. The study included 151 patients in total, and the Cox proportional hazard model was employed to look at diabetes patients' survival times. The log-rank test was performed to compare the categories of the variables, and Kaplan-Meier estimators were employed to predict the survival curves of diabetes patients. Result: Patients with type 2 diabetes had a median recovery time of 38 weeks, with the lowest and highest recovery times of 1 and 316 weeks, respectively. Patients with type 2 diabetes who took HCT and Regularly had a better probability of recovering from the condition sooner than those who took Doanied as prescribed by a doctor. Additionally, the likelihood of early recovery from type 2 diabetes mellitus improves by 1.7% as the patient's weight rises. Conclusion: Sex, age, family history, complications, smoking status, weight, and Spdrty (being HCT and Regular) were statistically significant variables at 0.05 p-values and are the key predictors for the recovery duration of type 2 DM patients. Therefore, future efforts to combat type 2 DM recovery should take all of these aspects into consideration. Prevention is crucial in the fight against type 2 diabetes. Adopting a healthy lifestyle, eating a well-balanced food, and getting enough exercise on a regular basis can help lower the chance of acquiring the illness. Furthermore, boosting awareness about the need of early identification and diabetes control education is critical in fostering a healthier society.
Abstract: Background: Diabetes mellitus, more often known as diabetes, is a dangerous, long-term (or "chronic") disorder that manifests as elevated blood glucose levels when the body is unable to create, sufficient amounts of, or utilize the insulin that is produced. Due to the fact that a single patient may recover from more than one type 2 diabetes through...
Show More
